KCAS Bio is happy to announce our participation in the 12th edition of the Antibody Industrial Symposium (AIS), taking place in Montpellier, France. As a premier event in the antibody and therapeutic development sector, AIS offers a unique platform for scientific exchange, collaboration, and innovation. We are excited to be part of this prestigious gathering, where we will showcase our cutting-edge bioanalytical solutions and engage with industry leaders to drive advancements in antibody research and development.

Our presence at AIS underscores our commitment to innovation and excellence in bioanalytical research. We will be presenting our latest findings and methodologies that are shaping the future of antibody therapeutics. From novel bioanalytical approaches to robust assay development, our presentations will demonstrate how KCAS Bio is pushing the boundaries of science to support the next generation of antibody-based treatments.

Dawn Dufield, PhD, Scientific Officer at KCAS Bio will be giving a talk on a groundbreaking PK bioanalytical approach. Join us on┬áJune 21 at 11:45 AM (CEST) in the Einstein Auditorium for her presentation on “Novel PK Bioanalytical Approach Using a 1.5 plex Hybrid LC-MS/MS Assay for Quantification of Total Drug (ADC/ARC) and Total Ab.”

We would be happy to collect and address your questions about Dawn’s presentation or any other inquiries on how our expertise can support your projects. Please feel free to reach out to us here.